US FDA’s Accelerated Approval Council: Bigger Role, More Transparency Coming?

The inspector general said the council should be more involved in specific approval decisions when there is internal disagreement, but FDA said that would preclude some individuals from adjudicating a subsequent withdrawal proceeding.

2024/2025 Pink Sheet Perspectives
The expedited withdrawal procedures were pressure-tested by Pepaxto in 2024. (Shutterstock)

More from Pink Sheet Perspectives

More from Pathways & Standards